Keymed Biosciences Announces 2026 H1 Results and Business Updates
CHENGDU, China, Aug. 21, 2026 /PRNewswire/ — On August 19, 2026, Keymed Biosciences (HKEX: 02162) announced its interim results for the six months ended June 30, 2026, with total revenue of RMB617 million.
